#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Propionic acidaemia Pseudomyxoma peritonei Retinal artery occlusion Precursor T-lymphoblastic lymphoma/leukaemia recurrent Pyruvate dehydrogenase complex deficiency Toxic epidermal necrolysis Insulinoma Autoinflammation with infantile enterocolitis Endometrial cancer Thyroid cancer metastatic Hypereosinophilic syndrome Malignant glioma Brain injury Arterial disorder Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Diagnostics Rhabdomyosarcoma – Trials in Disease X-linked lymphoproliferative syndrome – Treatment Leiomyosarcoma – Diagnostics Fabry’s disease – Treatment Hereditary ataxia – Diagnostics Angiosarcoma metastatic – Life with Disease Fragile X syndrome – Trials in Disease Krabbe’s disease – Treatment Acquired haemophilia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Capmatinib Cytisine Anidulafungin Marstacimab Ipilimumab Fondaparinux Sodium ENSIFENTRINE Midazolam Hydrochloride Azithromycin Lecanemab BENZYDAMINE HYDROCHLORIDE Fipaxalparant Acasunlimab BMS-986365 Flecainide Rasburicase Calcium Levofolinate PEGVISOMANT Olopatadine Hydrochloride Deferiprone More therapies…

    Learn about Your Condition

    Retinal vein occlusion Deafness neurosensory Breast conserving surgery Netherton's syndrome Yellow fever Syphilis Delayed graft function Osteoporosis postmenopausal Small for dates baby Ovarian cancer stage III Liposarcoma metastatic Intervertebral disc protrusion Meniere's disease B-cell type acute leukaemia Perthes disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effectiveness and Safety of Crovalimab for Children with Atypical Hemolytic Uremic Syndrome (aHUS)

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Crovalimab
    Belgium France Hungary Italy Poland Spain

  • Long-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • Sebetralstat
    Austria Bulgaria France Germany Greece Hungary +7

  • Study on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Diphenhydramine
    • Sabestomig
    • Epinephrine
    Denmark France Italy Spain

  • Study on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atypical haemolytic uraemic syndrome
    Investigated Drugs:
    • Crovalimab
    Belgium France Germany Hungary Italy Poland +1

  • Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Primary myelofibrosis
    Investigated Drugs:
    • Luspatercept
    • Sodium Chloride
    Austria Belgium Czechia France Germany Greece +6

  • Long-term Safety Study of Etranacogene Dezaparvovec in Adult Men with Hemophilia B

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    Investigated Drugs:
    • Etranacogene Dezaparvovec
    Belgium Denmark Germany Ireland The Netherlands Sweden
Previous Page
1 … 64 65 66 67 68 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!